Fetterman appealed to President Trump and Health and Human Services Secretary Robert F. Kennedy Jr. personally.

In a New York Times column this week, the Pennsylvania Democrat shared his experience taking Mounjaro while advocating for ...

The Centers for Medicare Medicaid Services (CMS) announced it will not proceed with a Biden administration proposal to expand ...

Medicare Advantage updates while halting proposed anti-obesity drug coverage, impacting millions of potential beneficiaries.

States increasingly struggling to cover the rising cost of popular GLP-1 drugs like Wegovy, Ozempic and Zepbound ... or “somewhat” favor having Medicare and Medicaid cover weight-loss drugs ...

Still, the Centers for Medicare and Medicaid Services didn’t entirely ... Shares in Novo Nordisk, which sells GLP-1s Wegovy ...

CMS keeps out LLY and NVO's obesity drugs from Medicare coverage. Medicare, at present, does not cover obesity drugs if they ...

States increasingly struggling to cover the rising cost of popular GLP-1 drugs like Wegovy, Ozempic and Zepbound are searching ... half of Americans "strongly" or "somewhat" favor having Medicare and ...